The Cancer Mutation D83V Induces an α-Helix to β-Strand Conformation Switch in MEF2B.
暂无分享,去创建一个
Yang Fu | Lin Chen | Yang Fu | X. Lei | Fang Wu | Yi Kou | Xiao Lei | Niroop Rajashekar | Haoran Shi | Fang Wu | Jiang Xu | Yibing Luo | Lin Chen | Y. Kou | Niroop Rajashekar | Jiang Xu | Haoran Shi | Yibing Luo
[1] P. Alexander,et al. A minimal sequence code for switching protein structure and function , 2009, Proceedings of the National Academy of Sciences.
[2] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[3] M. Gearing,et al. Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy , 2009, Science.
[4] E. Olson,et al. Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C. , 2009, Blood.
[5] Y. Kallberg,et al. Prediction of Amyloid Fibril-forming Proteins* , 2001, The Journal of Biological Chemistry.
[6] C Sander,et al. On the use of sequence homologies to predict protein structure: identical pentapeptides can have completely different conformations. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[7] Eric S. Lander,et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing , 2012, Proceedings of the National Academy of Sciences.
[8] M. Grütter,et al. Crystallization and structure solution of p53 (residues 326-356) by molecular replacement using an NMR model as template. , 1998, Acta crystallographica. Section D, Biological crystallography.
[9] Raul Rabadan,et al. Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma , 2011, Nature Genetics.
[10] H. Youn,et al. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. , 2000, Immunity.
[11] K. Webster,et al. Control of Cardiac-specific Transcription by p300 through Myocyte Enhancer Factor-2D* , 2001, The Journal of Biological Chemistry.
[12] Danielle Hulsman,et al. Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice , 2002, Nature Genetics.
[13] Alexei Vagin,et al. Molecular replacement with MOLREP. , 2010, Acta crystallographica. Section D, Biological crystallography.
[14] N. Copeland,et al. Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. , 2005, Blood.
[15] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[16] B. Black,et al. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins , 1995, Cell.
[17] K. Basso,et al. MEF2B mutations lead to deregulated expression of the BCL6 oncogene in Diffuse Large B cell Lymphoma , 2013, Nature Immunology.
[18] K. Sakaguchi,et al. Cancer-associated p53 Tetramerization Domain Mutants , 2010, The Journal of Biological Chemistry.
[19] S. Hunger,et al. Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia , 2005, Leukemia.
[20] M. Marra,et al. MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation , 2015, Nature Communications.
[21] Y. Kallberg,et al. Stabilization of discordant helices in amyloid fibril‐forming proteins , 2004, Protein science : a publication of the Protein Society.
[22] R. Burgess. Use of polyethyleneimine in purification of DNA-binding proteins. , 1991, Methods in enzymology.
[23] Bin Zhang,et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..
[24] F. Camargo,et al. Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c , 2009, Nature Immunology.
[25] Tom Royce,et al. A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.
[26] V. Kiermer,et al. HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. , 2003, Immunity.
[27] Takeshi Suzuki,et al. New genes involved in cancer identified by retroviral tagging , 2002, Nature Genetics.
[28] J. Harper,et al. A Calcium-Regulated MEF2 Sumoylation Switch Controls Postsynaptic Differentiation , 2006, Science.
[29] Randy J. Read,et al. Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.
[30] E. Olson,et al. MEF2: a calcium-dependent regulator of cell division, differentiation and death. , 2002, Trends in biochemical sciences.
[31] F. Cosset,et al. A Point Mutation in the N-Terminal Amphipathic Helix α0 in NS3 Promotes Hepatitis C Virus Assembly by Altering Core Localization to the Endoplasmic Reticulum and Facilitating Virus Budding , 2017, Journal of Virology.
[32] Richard A. Moore,et al. The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma. , 2013, Blood.
[33] J. Inazawa,et al. Identification of a novel fusion gene in a pre‐B acute lymphoblastic leukemia with t(1;19)(q23;p13) , 2004, Cancer science.
[34] Irina Artsimovitch,et al. An α Helix to β Barrel Domain Switch Transforms the Transcription Factor RfaH into a Translation Factor , 2012, Cell.
[35] N. Jayathilaka,et al. Structure of the MADS-box/MEF2 domain of MEF2A bound to DNA and its implication for myocardin recruitment. , 2010, Journal of molecular biology.
[36] E. Olson,et al. MEF2: a central regulator of diverse developmental programs , 2007, Development.
[37] Manel Juan,et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma , 2013, Proceedings of the National Academy of Sciences.
[38] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[39] H. Drexler,et al. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines , 2008, Leukemia.
[40] Andrey A Lebedev,et al. Space-group and origin ambiguity in macromolecular structures with pseudo-symmetry and its treatment with the program Zanuda. , 2014, Acta crystallographica. Section D, Biological crystallography.
[41] S. Hunger,et al. Cooperative transformation by MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins generated by the variant t(1;19) in acute lymphoblastic leukemia , 2007, Leukemia.
[42] E. Olson,et al. MEF2 responds to multiple calcium‐regulated signals in the control of skeletal muscle fiber type , 2000, The EMBO journal.
[43] P. Y. Chou,et al. Prediction of protein conformation. , 1974, Biochemistry.
[44] Philip R. Evans,et al. An introduction to data reduction: space-group determination, scaling and intensity statistics , 2011, Acta crystallographica. Section D, Biological crystallography.
[45] Song Tan,et al. Crystal structure of the yeast MATα2/MCM1/DNA ternary complex , 1998, Nature.
[46] Brian F. Volkman,et al. Interconversion between two unrelated protein folds in the lymphotactin native state , 2008, Proceedings of the National Academy of Sciences.
[47] E. Olson,et al. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. , 2000, Molecular cell.
[48] Lin Chen,et al. Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2 , 2003, Nature.
[49] E. Miska,et al. MEF‐2 function is modified by a novel co‐repressor, MITR , 1999, The EMBO journal.
[50] Da-Zhi Wang,et al. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. , 2008, The Journal of clinical investigation.
[51] Kohei Uosaki,et al. Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer. , 2006, Biochemistry.
[52] Jun O. Liu,et al. Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly , 2011, Nucleic acids research.
[53] J. Rizo,et al. The Mad2 spindle checkpoint protein has two distinct natively folded states , 2004, Nature Structural &Molecular Biology.
[54] C. Anfinsen. Principles that govern the folding of protein chains. , 1973, Science.
[55] David Dunson,et al. Genetic heterogeneity of diffuse large B-cell lymphoma , 2013, Proceedings of the National Academy of Sciences.
[56] G. Lyons,et al. Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes. , 1998, Molecular immunology.
[57] R. Epand,et al. Fusion peptides and the mechanism of viral fusion. , 2003, Biochimica et biophysica acta.
[58] T. Richmond,et al. Crystal structure of MEF2A core bound to DNA at 1.5 A resolution. , 2000, Journal of molecular biology.
[59] Ryan D. Morin,et al. Theoretical Investigation of the D83V Mutation within the Myocyte-Specific Enhancer Factor-2 Beta and Its Role in Cancer , 2013 .
[60] D. Thirumalai,et al. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments. , 2002, Biophysical journal.
[61] A. Sharrocks,et al. The MADS-box family of transcription factors. , 1995, European journal of biochemistry.
[62] Steven J. M. Jones,et al. Frequent mutation of histone modifying genes in non-Hodgkin lymphoma , 2011, Nature.
[63] L. Kedes,et al. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C , 1997, Molecular and cellular biology.
[64] O. Ornatsky,et al. MEF2 Protein Expression, DNA Binding Specificity and Complex Composition, and Transcriptional Activity in Muscle and Non-muscle Cells* , 1996, The Journal of Biological Chemistry.
[65] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[66] M. Marra,et al. MEF2 transcription factors: developmental regulators and emerging cancer genes , 2015, Oncotarget.
[67] N. Pannu,et al. REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.
[68] P. Harrison,et al. Discordant and chameleon sequences: Their distribution and implications for amyloidogenicity , 2011, Protein science : a publication of the Protein Society.
[69] T. Richmond,et al. The B‐box dominates SAP‐1–SRF interactions in the structure of the ternary complex , 2001, The EMBO journal.
[70] Lisa N Kinch,et al. ChSeq: A database of chameleon sequences , 2015, Protein science : a publication of the Protein Society.
[71] N. Jayathilaka,et al. Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2 , 2012, Nucleic acids research.
[72] A. Verdel,et al. mHDA1/HDAC5 Histone Deacetylase Interacts with and Represses MEF2A Transcriptional Activity* , 2000, The Journal of Biological Chemistry.
[73] G M Clore,et al. Solution structure of the MEF2A–DNA complex: structural basis for the modulation of DNA bending and specificity by MADS‐box transcription factors , 2000, The EMBO journal.
[74] Owen Johnson,et al. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM , 2011, Acta crystallographica. Section D, Biological crystallography.
[75] Jun O. Liu,et al. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2. , 2004, Journal of molecular biology.
[76] Steven W. Flavell,et al. Activity-Dependent Regulation of MEF2 Transcription Factors Suppresses Excitatory Synapse Number , 2006, Science.
[77] H. Arnold,et al. The myogenin gene is activated during myocyte differentiation by pre-existing, not newly synthesized transcription factor MEF-2. , 1994, The Journal of biological chemistry.
[78] J. Skehel,et al. Structure of influenza haemagglutinin at the pH of membrane fusion , 1994, Nature.
[79] Michael P. Eichenlaub,et al. A temporal map of transcription factor activity: mef2 directly regulates target genes at all stages of muscle development. , 2006, Developmental cell.
[80] T. Golub,et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.
[81] D Baker,et al. The sequences of small proteins are not extensively optimized for rapid folding by natural selection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[82] D. Figeys,et al. Skeletal myosin light chain kinase regulates skeletal myogenesis by phosphorylation of MEF2C , 2011, The EMBO journal.
[83] D. Dunson,et al. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma , 2017, Cell.
[84] F. Dequiedt,et al. Class II histone deacetylases: versatile regulators. , 2003, Trends in genetics : TIG.
[85] P. S. Kim,et al. Context is a major determinant of β-sheet propensity , 1994, Nature.